What is the dosage and how should it be used?

Etidronate comes as a tablet which is to be administered orally.

Take etidronate exactly as it was prescribed for you. Do not use the medication in larger amounts or for longer than recommended by your doctor.

Furthermore, do not crush, chew, or suck the pill. Swallow each etidronate tablet with a full glass (6 to 8 ounces) of water. Use only plain water (not mineral water) when taking an etidronate tablet.

For at least the first 2 hours after taking etidronate, do not eat or drink anything other than plain water, and do not take any other medicines including vitamins or mineral supplements.

It is important to take etidronate regularly to get the most benefit.

Paget's disease is usually treated for 30 to 60 days with etidronate. After you stop taking etidronate, you must stay off the medication for at least 90 days before starting etidronate therapy again.

To be sure this medication is helping your condition, your doctor will need to check your progress on a regular basis. It is important that you not miss any scheduled visits to your doctor.

Additionally, etidronate is only part of a complete program of treatment that may also include taking calcium and vitamin supplements. Follow your diet, medication, and exercise routines very closely.

 

FDA Information

Why is this medication prescribed?

Other uses for this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.